Details of the Drug

General Information of Drug (ID: DMYHIAR)

Drug Name
AdRTVP-1
Synonyms
AdRTVP-1, Baylor College of Medicine; Gene therapy (RTVP-1); Gene therapy (RTVP-1), Baylor College of Medicine; Related to Testes-Specific Vespid and Pathogenesis Protein-1 adenoviral gene therapy, BCM
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Phase 1 [1]
Cross-matching ID
TTD ID
D09RZH

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glioma pathogenesis-related protein 1 (GLIPR1) TTEQF1O GLIP1_HUMAN Modulator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

ICD Disease Classification 02 Neoplasm
Disease Class ICD-11: 2C82 Prostate cancer
The Studied Tissue Prostate
The Studied Disease Prostate cancer [ICD-11:2C82]
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Glioma pathogenesis-related protein 1 (GLIPR1) DTT GLIPR1 8.91E-01 0.43 0.45
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer. Cancer Gene Ther. 2006 Jul;13(7):658-63.